Y-Mabs Therapeutics's total assets for Q1 2025 were $112.61M, a decrease of -6.08% from the previous quarter. YMAB total liabilities were $23.16M for the fiscal quarter, a -17.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.